Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Go back to Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: ORKA) Delayed: 85.58 +0.20 (0.23%)
Previous Close $85.38    52 Week High
Open $84.01    52 Week Low
Day High $87.10    P/E N/A 
Day Low $83.41    EPS
Volume 586,595